nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—SLC22A2—Vinblastine—head and neck cancer	0.236	0.51	CbGbCtD
Procainamide—CYP2D6—Hydroxyurea—head and neck cancer	0.167	0.362	CbGbCtD
Procainamide—CYP2D6—Vinblastine—head and neck cancer	0.0591	0.128	CbGbCtD
Procainamide—SLC22A4—glottis—head and neck cancer	0.0443	0.227	CbGeAlD
Procainamide—Lupus erythematosus—Hydroxyurea—head and neck cancer	0.0185	0.0599	CcSEcCtD
Procainamide—Electrocardiogram change—Fluorouracil—head and neck cancer	0.0173	0.0562	CcSEcCtD
Procainamide—SLC22A4—larynx—head and neck cancer	0.0157	0.0802	CbGeAlD
Procainamide—Systemic lupus erythematosus—Hydroxyurea—head and neck cancer	0.0124	0.0403	CcSEcCtD
Procainamide—Pericarditis—Fluorouracil—head and neck cancer	0.0114	0.0371	CcSEcCtD
Procainamide—Drug fever—Docetaxel—head and neck cancer	0.0107	0.0347	CcSEcCtD
Procainamide—Lupus erythematosus—Docetaxel—head and neck cancer	0.00959	0.0311	CcSEcCtD
Procainamide—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.00727	0.0236	CcSEcCtD
Procainamide—SLC22A3—tongue—head and neck cancer	0.00658	0.0336	CbGeAlD
Procainamide—Systemic lupus erythematosus—Docetaxel—head and neck cancer	0.00645	0.0209	CcSEcCtD
Procainamide—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.00625	0.0203	CcSEcCtD
Procainamide—Hepatic failure—Hydroxyurea—head and neck cancer	0.00555	0.018	CcSEcCtD
Procainamide—DNMT1—parotid gland—head and neck cancer	0.00547	0.0279	CbGeAlD
Procainamide—Supraventricular tachycardia—Docetaxel—head and neck cancer	0.00545	0.0177	CcSEcCtD
Procainamide—DNMT1—saliva-secreting gland—head and neck cancer	0.00523	0.0268	CbGeAlD
Procainamide—DNMT1—connective tissue—head and neck cancer	0.00481	0.0246	CbGeAlD
Procainamide—Pleural effusion—Docetaxel—head and neck cancer	0.00466	0.0151	CcSEcCtD
Procainamide—DNMT1—epithelium—head and neck cancer	0.00457	0.0233	CbGeAlD
Procainamide—Rash maculo-papular—Fluorouracil—head and neck cancer	0.0045	0.0146	CcSEcCtD
Procainamide—SLC22A3—mouth—head and neck cancer	0.00443	0.0226	CbGeAlD
Procainamide—SCN11A—head—head and neck cancer	0.00434	0.0222	CbGeAlD
Procainamide—Depression—Vinblastine—head and neck cancer	0.00421	0.0137	CcSEcCtD
Procainamide—SCN7A—thyroid gland—head and neck cancer	0.00416	0.0213	CbGeAlD
Procainamide—SLC22A4—neck—head and neck cancer	0.00416	0.0213	CbGeAlD
Procainamide—DNMT1—trachea—head and neck cancer	0.00404	0.0206	CbGeAlD
Procainamide—Neutropenia—Hydroxyurea—head and neck cancer	0.00403	0.0131	CcSEcCtD
Procainamide—Agranulocytosis—Vinblastine—head and neck cancer	0.00394	0.0128	CcSEcCtD
Procainamide—Oliguria—Docetaxel—head and neck cancer	0.00388	0.0126	CcSEcCtD
Procainamide—SCN7A—head—head and neck cancer	0.00369	0.0189	CbGeAlD
Procainamide—Cardiac failure—Fluorouracil—head and neck cancer	0.00368	0.0119	CcSEcCtD
Procainamide—Lethargy—Fluorouracil—head and neck cancer	0.00367	0.0119	CcSEcCtD
Procainamide—DNMT1—lymphoid tissue—head and neck cancer	0.00352	0.018	CbGeAlD
Procainamide—Hallucination—Hydroxyurea—head and neck cancer	0.00344	0.0112	CcSEcCtD
Procainamide—Cardiac arrest—Fluorouracil—head and neck cancer	0.00342	0.0111	CcSEcCtD
Procainamide—SCN8A—head—head and neck cancer	0.00329	0.0168	CbGeAlD
Procainamide—Lightheadedness—Docetaxel—head and neck cancer	0.0032	0.0104	CcSEcCtD
Procainamide—DNMT1—thyroid gland—head and neck cancer	0.00319	0.0163	CbGeAlD
Procainamide—Chills—Hydroxyurea—head and neck cancer	0.0031	0.0101	CcSEcCtD
Procainamide—SLC22A3—parotid gland—head and neck cancer	0.00308	0.0158	CbGeAlD
Procainamide—Eosinophilia—Fluorouracil—head and neck cancer	0.00307	0.00998	CcSEcCtD
Procainamide—Ill-defined disorder—Vinblastine—head and neck cancer	0.00306	0.00993	CcSEcCtD
Procainamide—Malaise—Vinblastine—head and neck cancer	0.00297	0.00965	CcSEcCtD
Procainamide—SLC22A3—saliva-secreting gland—head and neck cancer	0.00295	0.0151	CbGeAlD
Procainamide—SCN4A—thyroid gland—head and neck cancer	0.00291	0.0149	CbGeAlD
Procainamide—Hepatic failure—Docetaxel—head and neck cancer	0.00289	0.00937	CcSEcCtD
Procainamide—Convulsion—Vinblastine—head and neck cancer	0.00286	0.00927	CcSEcCtD
Procainamide—DNMT1—head—head and neck cancer	0.00283	0.0145	CbGeAlD
Procainamide—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00279	0.00905	CcSEcCtD
Procainamide—Discomfort—Vinblastine—head and neck cancer	0.00277	0.009	CcSEcCtD
Procainamide—Atrial fibrillation—Docetaxel—head and neck cancer	0.00274	0.00888	CcSEcCtD
Procainamide—SCN10A—lymphoid tissue—head and neck cancer	0.00273	0.014	CbGeAlD
Procainamide—Renal impairment—Docetaxel—head and neck cancer	0.00272	0.00884	CcSEcCtD
Procainamide—SLC22A3—connective tissue—head and neck cancer	0.00271	0.0139	CbGeAlD
Procainamide—Malaise—Hydroxyurea—head and neck cancer	0.00271	0.0088	CcSEcCtD
Procainamide—Cardiac failure—Docetaxel—head and neck cancer	0.00266	0.00862	CcSEcCtD
Procainamide—Lethargy—Docetaxel—head and neck cancer	0.00265	0.00859	CcSEcCtD
Procainamide—Thrombocytopenia—Vinblastine—head and neck cancer	0.00263	0.00855	CcSEcCtD
Procainamide—Convulsion—Hydroxyurea—head and neck cancer	0.0026	0.00845	CcSEcCtD
Procainamide—Lidocaine—EGFR—head and neck cancer	0.0026	1	CrCbGaD
Procainamide—ACHE—thyroid gland—head and neck cancer	0.0026	0.0133	CbGeAlD
Procainamide—Agranulocytosis—Fluorouracil—head and neck cancer	0.00258	0.00839	CcSEcCtD
Procainamide—SCN7A—lymph node—head and neck cancer	0.00258	0.0132	CbGeAlD
Procainamide—SCN4A—head—head and neck cancer	0.00258	0.0132	CbGeAlD
Procainamide—Anorexia—Vinblastine—head and neck cancer	0.00256	0.00832	CcSEcCtD
Procainamide—Discomfort—Hydroxyurea—head and neck cancer	0.00253	0.00821	CcSEcCtD
Procainamide—SLC22A4—trachea—head and neck cancer	0.0025	0.0128	CbGeAlD
Procainamide—SCN1A—head—head and neck cancer	0.00249	0.0127	CbGeAlD
Procainamide—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.0024	0.0078	CcSEcCtD
Procainamide—Abdominal pain upper—Docetaxel—head and neck cancer	0.00237	0.00769	CcSEcCtD
Procainamide—Anorexia—Hydroxyurea—head and neck cancer	0.00234	0.00759	CcSEcCtD
Procainamide—Decreased appetite—Vinblastine—head and neck cancer	0.00234	0.00759	CcSEcCtD
Procainamide—SCN2A—head—head and neck cancer	0.00228	0.0117	CbGeAlD
Procainamide—SCN3A—thyroid gland—head and neck cancer	0.00226	0.0116	CbGeAlD
Procainamide—SLC22A5—parotid gland—head and neck cancer	0.00224	0.0115	CbGeAlD
Procainamide—Feeling abnormal—Vinblastine—head and neck cancer	0.00222	0.00719	CcSEcCtD
Procainamide—SCN10A—head—head and neck cancer	0.0022	0.0112	CbGeAlD
Procainamide—Gastrointestinal pain—Vinblastine—head and neck cancer	0.0022	0.00714	CcSEcCtD
Procainamide—SLC22A5—saliva-secreting gland—head and neck cancer	0.00215	0.011	CbGeAlD
Procainamide—Decreased appetite—Hydroxyurea—head and neck cancer	0.00213	0.00692	CcSEcCtD
Procainamide—Abdominal pain—Vinblastine—head and neck cancer	0.00213	0.0069	CcSEcCtD
Procainamide—Neutropenia—Docetaxel—head and neck cancer	0.0021	0.0068	CcSEcCtD
Procainamide—SCN9A—lymph node—head and neck cancer	0.00202	0.0103	CbGeAlD
Procainamide—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00202	0.00656	CcSEcCtD
Procainamide—SCN3A—head—head and neck cancer	0.00201	0.0103	CbGeAlD
Procainamide—SCN5A—head—head and neck cancer	0.002	0.0102	CbGeAlD
Procainamide—DNMT1—lymph node—head and neck cancer	0.00198	0.0101	CbGeAlD
Procainamide—Hypersensitivity—Vinblastine—head and neck cancer	0.00198	0.00643	CcSEcCtD
Procainamide—SLC22A4—thyroid gland—head and neck cancer	0.00198	0.0101	CbGeAlD
Procainamide—Renal failure—Docetaxel—head and neck cancer	0.00196	0.00638	CcSEcCtD
Procainamide—Body temperature increased—Hydroxyurea—head and neck cancer	0.00194	0.00629	CcSEcCtD
Procainamide—Asthenia—Vinblastine—head and neck cancer	0.00193	0.00626	CcSEcCtD
Procainamide—Convulsion—Fluorouracil—head and neck cancer	0.00187	0.00608	CcSEcCtD
Procainamide—Agranulocytosis—Docetaxel—head and neck cancer	0.00186	0.00605	CcSEcCtD
Procainamide—Myalgia—Fluorouracil—head and neck cancer	0.00184	0.00598	CcSEcCtD
Procainamide—Diarrhoea—Vinblastine—head and neck cancer	0.00184	0.00597	CcSEcCtD
Procainamide—Discomfort—Fluorouracil—head and neck cancer	0.00182	0.00591	CcSEcCtD
Procainamide—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00181	0.00587	CcSEcCtD
Procainamide—SLC22A3—thyroid gland—head and neck cancer	0.0018	0.00921	CbGeAlD
Procainamide—Confusional state—Fluorouracil—head and neck cancer	0.00178	0.00578	CcSEcCtD
Procainamide—Dizziness—Vinblastine—head and neck cancer	0.00178	0.00577	CcSEcCtD
Procainamide—Asthenia—Hydroxyurea—head and neck cancer	0.00176	0.00571	CcSEcCtD
Procainamide—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00173	0.00561	CcSEcCtD
Procainamide—Vomiting—Vinblastine—head and neck cancer	0.00171	0.00555	CcSEcCtD
Procainamide—CHRM2—head—head and neck cancer	0.0017	0.0087	CbGeAlD
Procainamide—Anorexia—Fluorouracil—head and neck cancer	0.00168	0.00546	CcSEcCtD
Procainamide—Diarrhoea—Hydroxyurea—head and neck cancer	0.00168	0.00545	CcSEcCtD
Procainamide—SLC22A1—head—head and neck cancer	0.00167	0.00855	CbGeAlD
Procainamide—Cardiac disorder—Docetaxel—head and neck cancer	0.00166	0.0054	CcSEcCtD
Procainamide—Flushing—Docetaxel—head and neck cancer	0.00166	0.0054	CcSEcCtD
Procainamide—SLC22A5—trachea—head and neck cancer	0.00166	0.00846	CbGeAlD
Procainamide—Hypotension—Fluorouracil—head and neck cancer	0.00165	0.00536	CcSEcCtD
Procainamide—Dizziness—Hydroxyurea—head and neck cancer	0.00162	0.00527	CcSEcCtD
Procainamide—BCHE—trachea—head and neck cancer	0.00161	0.00824	CbGeAlD
Procainamide—ACHE—lymph node—head and neck cancer	0.00161	0.00824	CbGeAlD
Procainamide—Chills—Docetaxel—head and neck cancer	0.00161	0.00522	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00161	0.00522	CcSEcCtD
Procainamide—SLC22A3—head—head and neck cancer	0.0016	0.00817	CbGeAlD
Procainamide—Nausea—Vinblastine—head and neck cancer	0.0016	0.00519	CcSEcCtD
Procainamide—Vomiting—Hydroxyurea—head and neck cancer	0.00156	0.00506	CcSEcCtD
Procainamide—SCN10A—lymph node—head and neck cancer	0.00154	0.00788	CbGeAlD
Procainamide—Decreased appetite—Fluorouracil—head and neck cancer	0.00153	0.00498	CcSEcCtD
Procainamide—Dysgeusia—Docetaxel—head and neck cancer	0.00153	0.00496	CcSEcCtD
Procainamide—Nausea—Hydroxyurea—head and neck cancer	0.00146	0.00473	CcSEcCtD
Procainamide—Feeling abnormal—Fluorouracil—head and neck cancer	0.00146	0.00472	CcSEcCtD
Procainamide—SCN3A—lymph node—head and neck cancer	0.0014	0.00718	CbGeAlD
Procainamide—Urticaria—Fluorouracil—head and neck cancer	0.0014	0.00455	CcSEcCtD
Procainamide—Body temperature increased—Fluorouracil—head and neck cancer	0.0014	0.00453	CcSEcCtD
Procainamide—Convulsion—Docetaxel—head and neck cancer	0.00135	0.00439	CcSEcCtD
Procainamide—Arthralgia—Docetaxel—head and neck cancer	0.00133	0.00432	CcSEcCtD
Procainamide—Myalgia—Docetaxel—head and neck cancer	0.00133	0.00432	CcSEcCtD
Procainamide—SLC22A5—thyroid gland—head and neck cancer	0.00131	0.0067	CbGeAlD
Procainamide—Hypersensitivity—Fluorouracil—head and neck cancer	0.0013	0.00422	CcSEcCtD
Procainamide—Confusional state—Docetaxel—head and neck cancer	0.00129	0.00417	CcSEcCtD
Procainamide—BCHE—thyroid gland—head and neck cancer	0.00128	0.00652	CbGeAlD
Procainamide—Shock—Docetaxel—head and neck cancer	0.00125	0.00407	CcSEcCtD
Procainamide—Pruritus—Fluorouracil—head and neck cancer	0.00125	0.00405	CcSEcCtD
Procainamide—Thrombocytopenia—Docetaxel—head and neck cancer	0.00125	0.00405	CcSEcCtD
Procainamide—SLC22A4—lymph node—head and neck cancer	0.00123	0.00629	CbGeAlD
Procainamide—Anorexia—Docetaxel—head and neck cancer	0.00121	0.00394	CcSEcCtD
Procainamide—Diarrhoea—Fluorouracil—head and neck cancer	0.00121	0.00392	CcSEcCtD
Procainamide—Hypotension—Docetaxel—head and neck cancer	0.00119	0.00387	CcSEcCtD
Procainamide—Dizziness—Fluorouracil—head and neck cancer	0.00117	0.00379	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00116	0.00377	CcSEcCtD
Procainamide—BCHE—head—head and neck cancer	0.00113	0.00579	CbGeAlD
Procainamide—Vomiting—Fluorouracil—head and neck cancer	0.00112	0.00364	CcSEcCtD
Procainamide—SLC22A3—lymph node—head and neck cancer	0.00112	0.00572	CbGeAlD
Procainamide—Decreased appetite—Docetaxel—head and neck cancer	0.00111	0.0036	CcSEcCtD
Procainamide—Feeling abnormal—Docetaxel—head and neck cancer	0.00105	0.00341	CcSEcCtD
Procainamide—Nausea—Fluorouracil—head and neck cancer	0.00105	0.0034	CcSEcCtD
Procainamide—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00104	0.00338	CcSEcCtD
Procainamide—Body temperature increased—Docetaxel—head and neck cancer	0.00101	0.00327	CcSEcCtD
Procainamide—Abdominal pain—Docetaxel—head and neck cancer	0.00101	0.00327	CcSEcCtD
Procainamide—Hypersensitivity—Docetaxel—head and neck cancer	0.000939	0.00305	CcSEcCtD
Procainamide—Asthenia—Docetaxel—head and neck cancer	0.000914	0.00297	CcSEcCtD
Procainamide—Pruritus—Docetaxel—head and neck cancer	0.000902	0.00293	CcSEcCtD
Procainamide—Diarrhoea—Docetaxel—head and neck cancer	0.000872	0.00283	CcSEcCtD
Procainamide—Dizziness—Docetaxel—head and neck cancer	0.000843	0.00274	CcSEcCtD
Procainamide—SLC22A5—lymph node—head and neck cancer	0.000814	0.00416	CbGeAlD
Procainamide—Vomiting—Docetaxel—head and neck cancer	0.00081	0.00263	CcSEcCtD
Procainamide—BCHE—lymph node—head and neck cancer	0.000792	0.00405	CbGeAlD
Procainamide—Nausea—Docetaxel—head and neck cancer	0.000757	0.00246	CcSEcCtD
Procainamide—CYP2D6—head—head and neck cancer	0.00075	0.00383	CbGeAlD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	6.95e-05	0.00218	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—VEGFA—head and neck cancer	6.89e-05	0.00216	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—STAT3—head and neck cancer	6.88e-05	0.00216	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—MAPK3—head and neck cancer	6.81e-05	0.00214	CbGpPWpGaD
Procainamide—BCHE—Phospholipid metabolism—PTEN—head and neck cancer	6.66e-05	0.00209	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—VEGFA—head and neck cancer	6.62e-05	0.00208	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—VEGFA—head and neck cancer	6.62e-05	0.00208	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	6.6e-05	0.00207	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—MAPK3—head and neck cancer	6.57e-05	0.00206	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—MAPK3—head and neck cancer	6.52e-05	0.00204	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—MAPK1—head and neck cancer	6.48e-05	0.00203	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—EGFR—head and neck cancer	6.48e-05	0.00203	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—HRAS—head and neck cancer	6.43e-05	0.00202	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—VEGFA—head and neck cancer	6.38e-05	0.002	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—VEGFA—head and neck cancer	6.38e-05	0.002	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—VEGFA—head and neck cancer	6.35e-05	0.00199	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—STAT3—head and neck cancer	6.29e-05	0.00197	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—MAPK3—head and neck cancer	6.26e-05	0.00196	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—MAPK3—head and neck cancer	6.26e-05	0.00196	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—MAPK1—head and neck cancer	6.25e-05	0.00196	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—EGFR—head and neck cancer	6.25e-05	0.00196	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—MAPK1—head and neck cancer	6.2e-05	0.00195	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—EGFR—head and neck cancer	6.2e-05	0.00194	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—MAPK3—head and neck cancer	6.04e-05	0.00189	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—MAPK3—head and neck cancer	6.04e-05	0.00189	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—MAPK3—head and neck cancer	6.01e-05	0.00189	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	5.96e-05	0.00187	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—MAPK1—head and neck cancer	5.96e-05	0.00187	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—MAPK1—head and neck cancer	5.96e-05	0.00187	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—EGFR—head and neck cancer	5.96e-05	0.00187	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—EGFR—head and neck cancer	5.96e-05	0.00187	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	5.76e-05	0.00181	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—MAPK1—head and neck cancer	5.74e-05	0.0018	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—MAPK1—head and neck cancer	5.74e-05	0.0018	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—EGFR—head and neck cancer	5.74e-05	0.0018	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—EGFR—head and neck cancer	5.74e-05	0.0018	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—MAPK1—head and neck cancer	5.72e-05	0.00179	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—EGFR—head and neck cancer	5.72e-05	0.00179	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—HRAS—head and neck cancer	5.63e-05	0.00177	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—NAT2—head and neck cancer	5.6e-05	0.00176	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—KISS1—head and neck cancer	5.49e-05	0.00172	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—NOTCH1—head and neck cancer	5.47e-05	0.00172	CbGpPWpGaD
Procainamide—ACHE—Phospholipid metabolism—PIK3CA—head and neck cancer	5.27e-05	0.00165	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	5.22e-05	0.00164	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—HRAS—head and neck cancer	5.2e-05	0.00163	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	5.2e-05	0.00163	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—NOTCH1—head and neck cancer	5.17e-05	0.00162	CbGpPWpGaD
Procainamide—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	5.15e-05	0.00162	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—VEGFA—head and neck cancer	5.14e-05	0.00161	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—STAT3—head and neck cancer	5.09e-05	0.0016	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—HRAS—head and neck cancer	5.02e-05	0.00158	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—KISS1—head and neck cancer	4.98e-05	0.00156	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—HRAS—head and neck cancer	4.98e-05	0.00156	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—AKT1—head and neck cancer	4.97e-05	0.00156	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	4.95e-05	0.00155	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	4.92e-05	0.00154	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—VEGFA—head and neck cancer	4.92e-05	0.00154	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—DPYD—head and neck cancer	4.91e-05	0.00154	CbGpPWpGaD
Procainamide—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	4.88e-05	0.00153	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—STAT3—head and neck cancer	4.87e-05	0.00153	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—MAPK3—head and neck cancer	4.86e-05	0.00153	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—HRAS—head and neck cancer	4.78e-05	0.0015	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—HRAS—head and neck cancer	4.78e-05	0.0015	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—VEGFA—head and neck cancer	4.72e-05	0.00148	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—VEGFA—head and neck cancer	4.72e-05	0.00148	CbGpPWpGaD
Procainamide—BCHE—Phospholipid metabolism—PIK3CA—head and neck cancer	4.7e-05	0.00147	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.68e-05	0.00147	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	4.68e-05	0.00147	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	4.68e-05	0.00147	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—STAT3—head and neck cancer	4.68e-05	0.00147	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—STAT3—head and neck cancer	4.68e-05	0.00147	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—YAP1—head and neck cancer	4.66e-05	0.00146	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—MAPK3—head and neck cancer	4.65e-05	0.00146	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.63e-05	0.00145	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—MAPK1—head and neck cancer	4.63e-05	0.00145	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—EGFR—head and neck cancer	4.62e-05	0.00145	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—HRAS—head and neck cancer	4.61e-05	0.00145	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—HRAS—head and neck cancer	4.61e-05	0.00145	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—HRAS—head and neck cancer	4.59e-05	0.00144	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—VEGFA—head and neck cancer	4.55e-05	0.00143	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—VEGFA—head and neck cancer	4.55e-05	0.00143	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—GRP—head and neck cancer	4.52e-05	0.00142	CbGpPWpGaD
Procainamide—ACHE—Transmission across Chemical Synapses—MAPK1—head and neck cancer	4.51e-05	0.00142	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—STAT3—head and neck cancer	4.51e-05	0.00141	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—STAT3—head and neck cancer	4.51e-05	0.00141	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—VEGFA—head and neck cancer	4.49e-05	0.00141	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—MAPK3—head and neck cancer	4.47e-05	0.0014	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—MAPK3—head and neck cancer	4.47e-05	0.0014	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—AKT1—head and neck cancer	4.43e-05	0.00139	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—MAPK1—head and neck cancer	4.42e-05	0.00139	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—EGFR—head and neck cancer	4.42e-05	0.00139	CbGpPWpGaD
Procainamide—ACHE—Metabolism—NAT2—head and neck cancer	4.41e-05	0.00138	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—UROD—head and neck cancer	4.35e-05	0.00137	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—MAPK3—head and neck cancer	4.31e-05	0.00135	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—MAPK3—head and neck cancer	4.31e-05	0.00135	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—MAPK1—head and neck cancer	4.25e-05	0.00133	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—MAPK1—head and neck cancer	4.25e-05	0.00133	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—EGFR—head and neck cancer	4.25e-05	0.00133	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—EGFR—head and neck cancer	4.25e-05	0.00133	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—MAPK3—head and neck cancer	4.24e-05	0.00133	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.18e-05	0.00131	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	4.15e-05	0.0013	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.13e-05	0.0013	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—GRP—head and neck cancer	4.1e-05	0.00129	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—MAPK1—head and neck cancer	4.1e-05	0.00129	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—MAPK1—head and neck cancer	4.1e-05	0.00129	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—EGFR—head and neck cancer	4.1e-05	0.00129	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—EGFR—head and neck cancer	4.1e-05	0.00129	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—MAPK3—head and neck cancer	4.07e-05	0.00128	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	4.06e-05	0.00127	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—AKT1—head and neck cancer	4.05e-05	0.00127	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—MAPK1—head and neck cancer	4.04e-05	0.00127	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—EGFR—head and neck cancer	4.04e-05	0.00127	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—MAPK1—head and neck cancer	4.02e-05	0.00126	CbGpPWpGaD
Procainamide—BCHE—Metabolism—NAT2—head and neck cancer	3.93e-05	0.00123	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	3.93e-05	0.00123	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—MAPK1—head and neck cancer	3.88e-05	0.00122	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—EGFR—head and neck cancer	3.88e-05	0.00122	CbGpPWpGaD
Procainamide—ACHE—Metabolism—DPYD—head and neck cancer	3.86e-05	0.00121	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—HRAS—head and neck cancer	3.71e-05	0.00117	CbGpPWpGaD
Procainamide—ACHE—Metabolism—YAP1—head and neck cancer	3.67e-05	0.00115	CbGpPWpGaD
Procainamide—ACHE—Transmission across Chemical Synapses—HRAS—head and neck cancer	3.62e-05	0.00114	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	3.59e-05	0.00113	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—HRAS—head and neck cancer	3.55e-05	0.00111	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—NAT2—head and neck cancer	3.51e-05	0.0011	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—MAPK1—head and neck cancer	3.46e-05	0.00108	CbGpPWpGaD
Procainamide—BCHE—Metabolism—DPYD—head and neck cancer	3.45e-05	0.00108	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—HRAS—head and neck cancer	3.41e-05	0.00107	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—HRAS—head and neck cancer	3.41e-05	0.00107	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—head and neck cancer	3.36e-05	0.00106	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—MAPK1—head and neck cancer	3.35e-05	0.00105	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	3.32e-05	0.00104	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—HRAS—head and neck cancer	3.29e-05	0.00103	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—HRAS—head and neck cancer	3.29e-05	0.00103	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—AKT1—head and neck cancer	3.28e-05	0.00103	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—NAT2—head and neck cancer	3.27e-05	0.00103	CbGpPWpGaD
Procainamide—BCHE—Metabolism—YAP1—head and neck cancer	3.27e-05	0.00103	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—HRAS—head and neck cancer	3.24e-05	0.00102	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—HRAS—head and neck cancer	3.23e-05	0.00101	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—VEGFA—head and neck cancer	3.2e-05	0.001	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—STAT3—head and neck cancer	3.17e-05	0.000995	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—AKT1—head and neck cancer	3.14e-05	0.000984	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—MAPK1—head and neck cancer	3.08e-05	0.000967	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—DPYD—head and neck cancer	3.08e-05	0.000966	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—MAPK3—head and neck cancer	3.03e-05	0.00095	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—AKT1—head and neck cancer	3.01e-05	0.000945	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—AKT1—head and neck cancer	3.01e-05	0.000945	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—KISS1—head and neck cancer	2.94e-05	0.000924	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—YAP1—head and neck cancer	2.92e-05	0.000917	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—AKT1—head and neck cancer	2.91e-05	0.000912	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—AKT1—head and neck cancer	2.91e-05	0.000912	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—HRAS—head and neck cancer	2.88e-05	0.000905	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—MAPK1—head and neck cancer	2.88e-05	0.000904	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—EGFR—head and neck cancer	2.88e-05	0.000904	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—DPYD—head and neck cancer	2.87e-05	0.000901	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—MAPK3—head and neck cancer	2.86e-05	0.000897	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—TYMS—head and neck cancer	2.8e-05	0.000878	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—HRAS—head and neck cancer	2.77e-05	0.00087	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GSTM1—head and neck cancer	2.77e-05	0.000868	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.76e-05	0.000865	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—MAPK1—head and neck cancer	2.75e-05	0.000864	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—YAP1—head and neck cancer	2.72e-05	0.000855	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—HRAS—head and neck cancer	2.69e-05	0.000844	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GPX1—head and neck cancer	2.65e-05	0.000831	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CYP1A1—head and neck cancer	2.62e-05	0.000823	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—MAPK1—head and neck cancer	2.57e-05	0.000805	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—HRAS—head and neck cancer	2.47e-05	0.000777	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.46e-05	0.000771	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GRP—head and neck cancer	2.42e-05	0.000761	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.4e-05	0.000754	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—STAT6—head and neck cancer	2.35e-05	0.000739	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—HRAS—head and neck cancer	2.31e-05	0.000726	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—HRAS—head and neck cancer	2.21e-05	0.000694	CbGpPWpGaD
Procainamide—ACHE—Metabolism—TYMS—head and neck cancer	2.2e-05	0.000691	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GSTM1—head and neck cancer	2.18e-05	0.000683	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.14e-05	0.000673	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GPX1—head and neck cancer	2.08e-05	0.000654	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—YAP1—head and neck cancer	2.08e-05	0.000654	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CYP1A1—head and neck cancer	2.06e-05	0.000648	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—HRAS—head and neck cancer	2.06e-05	0.000646	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—AKT1—head and neck cancer	2.04e-05	0.000641	CbGpPWpGaD
Procainamide—BCHE—Metabolism—TYMS—head and neck cancer	1.96e-05	0.000616	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GSTM1—head and neck cancer	1.94e-05	0.000609	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—AKT1—head and neck cancer	1.93e-05	0.000605	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GPX1—head and neck cancer	1.86e-05	0.000584	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP1A1—head and neck cancer	1.84e-05	0.000578	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NAT2—head and neck cancer	1.81e-05	0.000567	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—TYMS—head and neck cancer	1.75e-05	0.000551	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GSTM1—head and neck cancer	1.73e-05	0.000544	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.7e-05	0.000532	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GPX1—head and neck cancer	1.66e-05	0.000521	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP1A1—head and neck cancer	1.64e-05	0.000516	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—TYMS—head and neck cancer	1.64e-05	0.000513	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GSTM1—head and neck cancer	1.62e-05	0.000507	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—DPYD—head and neck cancer	1.59e-05	0.000497	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PTGS2—head and neck cancer	1.56e-05	0.000489	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GPX1—head and neck cancer	1.55e-05	0.000486	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP1A1—head and neck cancer	1.53e-05	0.000481	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.51e-05	0.000475	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—YAP1—head and neck cancer	1.5e-05	0.000472	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PTEN—head and neck cancer	1.36e-05	0.000427	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PTGS2—head and neck cancer	1.23e-05	0.000385	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—IL2—head and neck cancer	1.2e-05	0.000378	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PTGS2—head and neck cancer	1.09e-05	0.000344	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL2—head and neck cancer	1.09e-05	0.000343	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PTEN—head and neck cancer	1.07e-05	0.000336	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PTGS2—head and neck cancer	9.78e-06	0.000307	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PIK3CA—head and neck cancer	9.59e-06	0.000301	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PTEN—head and neck cancer	9.55e-06	0.0003	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NOTCH1—head and neck cancer	9.39e-06	0.000295	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PTGS2—head and neck cancer	9.11e-06	0.000286	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—TYMS—head and neck cancer	9.03e-06	0.000283	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GSTM1—head and neck cancer	8.93e-06	0.00028	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—MAPK3—head and neck cancer	8.79e-06	0.000276	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GPX1—head and neck cancer	8.55e-06	0.000268	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PTEN—head and neck cancer	8.53e-06	0.000268	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP1A1—head and neck cancer	8.46e-06	0.000266	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—MAPK1—head and neck cancer	8.37e-06	0.000263	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—EGFR—head and neck cancer	8.37e-06	0.000262	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PIK3CA—head and neck cancer	8e-06	0.000251	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PTEN—head and neck cancer	7.95e-06	0.000249	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—AKT1—head and neck cancer	7.84e-06	0.000246	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PIK3CA—head and neck cancer	7.55e-06	0.000237	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PIK3CA—head and neck cancer	7.26e-06	0.000228	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PIK3CA—head and neck cancer	6.74e-06	0.000211	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HRAS—head and neck cancer	6.72e-06	0.000211	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AKT1—head and neck cancer	6.53e-06	0.000205	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL2—head and neck cancer	6.46e-06	0.000203	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCND1—head and neck cancer	6.3e-06	0.000198	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AKT1—head and neck cancer	6.17e-06	0.000194	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PTEN—head and neck cancer	6.08e-06	0.000191	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PIK3CA—head and neck cancer	6.02e-06	0.000189	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AKT1—head and neck cancer	5.93e-06	0.000186	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PIK3CA—head and neck cancer	5.61e-06	0.000176	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AKT1—head and neck cancer	5.5e-06	0.000173	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—VEGFA—head and neck cancer	5.49e-06	0.000172	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—STAT3—head and neck cancer	5.44e-06	0.000171	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MAPK3—head and neck cancer	5.19e-06	0.000163	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PTGS2—head and neck cancer	5.03e-06	0.000158	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MAPK1—head and neck cancer	4.94e-06	0.000155	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EGFR—head and neck cancer	4.94e-06	0.000155	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AKT1—head and neck cancer	4.91e-06	0.000154	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AKT1—head and neck cancer	4.58e-06	0.000144	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PTEN—head and neck cancer	4.39e-06	0.000138	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PIK3CA—head and neck cancer	4.29e-06	0.000135	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TP53—head and neck cancer	4.15e-06	0.00013	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HRAS—head and neck cancer	3.97e-06	0.000125	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AKT1—head and neck cancer	3.5e-06	0.00011	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PIK3CA—head and neck cancer	3.1e-06	9.72e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AKT1—head and neck cancer	2.53e-06	7.94e-05	CbGpPWpGaD
